Concomitant hepatic radiation and intraarterial fluorinated pyrimidine therapy: Correlation of liver scan, liver function tests, and plasma CEA with tumor response

Sixteen Patients With Metastatic Disease to the Liver (12 Colorectal And Four Unknown Primary Tumors) Were Treated In A Pilot Study Of Hepatic Irradiation (2500‐3000 Rads In 10‐12 Fractions) Delivered Concomitantly With Continuous Short‐Term Intraarterial Infusion Of 5‐Fluorouracil (1 G/D) Or Fudr (0.5 Mg/Kg/D) Via A Percutaneously Placed Hepatic Artery Catheter. Abnormal Liver Function Tests, including SGOT, LDH, and alkaline phosphatase, decreased in all patients by day 7‐10 of treatment, and other metabolic factors, including serum cholesterol, calcium, albumin, phosphorous, and uric acid, also decreased, often to subnormal levels by termination of treatment (day 15‐20). These chemical alterations did not correlate with tumor response in that the identical pattern was observed in responders (ten patients) as well as nonresponders (six patients). Objective determinants of response were assessed by serial monitoring of plasma carcinoembryonic antigen (CEA) and liver scan. In 14 patients with elevated CEA levels, tumor response (nine patients), nonresponse (four patients), and relapse (five patients) was predicted and confirmed by sequential monitoring of CEA. In one patient, a paradoxical decrease in plasma CEA was associated with progressive disease. The liver scan identified all responding patients but was difficult to quantitate and was delayed for months following subjective clinical response and changes in plasma CEA levels.

[1]  T. Phillips,et al.  Combined modality therapy of hepatic metastasis , 1979, Cancer.

[2]  W. Looney,et al.  Solid tumor models for the assessment of different treatment modalities XII. Combined chemotherapy‐radiotherapy: Variation of time interval between time of administration of 5‐fluorouracil and radiation and its effect on the control of tumor growth , 1979, Cancer.

[3]  V. Rege,et al.  A combined treatment approach to management of hepatic metastases , 1977 .

[4]  J. Lokich,et al.  Carcinoid of the thymus with hereditary hyperparathyroidism. , 1978, Annals of internal medicine.

[5]  R. Mayer,et al.  Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer , 1978, Cancer.

[6]  D. M. Sherman,et al.  Palliation of hepatic metastasis , 1978, Cancer.

[7]  E. Borden,et al.  Further clinical studies with intrahepatic arterial infusion with 5‐fluorouracil , 1975, Cancer.

[8]  I. Kazem,et al.  Palliative irradiation for liver metastases. , 1975, JAMA.

[9]  B. Cady,et al.  Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. , 1974, American journal of surgery.

[10]  G. Ramírez,et al.  Intrahepatic arterial infusion with 5‐fluorouracil , 1972, Wisconsin medical journal.

[11]  C. Heidelberger,et al.  Studies on fluorinated pyrimidines. II. Effects on transplanted tumors. , 1958, Cancer research.

[12]  M. Clouse,et al.  Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. , 1983, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[13]  M. S. Lee,et al.  Irradiation of hepatic metastases. , 1977, International journal of radiation oncology, biology, physics.